Biomea Fusion, Inc.

BMEA Nasdaq SEC CIK 1840439
Follow Biomea Fusion Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$6.2M +62.3% vs same quarter last year
EPS, diluted −$0.09 +66.7% vs same quarter last year
Operating cash flow −$8.4M +27% vs same quarter last year
Operating income −$13M +37.7% vs same quarter last year
Net income by quarter
−$29.3M
−$29.3M
−$20.7M
−$16.4M
$4.6M
−$12.4M
−$8.3M
−$6.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$61.8M
FY24−$138.4M
FY23−$117.3M
FY22−$81.8M
FY21−$41.6M
FY20−$5.3M
FY19−$1.2M
FY18-
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$120.3M
FY23−$100M
FY22−$63.4M
FY21−$38.6M
FY20−$4.5M
FY19-
FY18-